Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Andexxa Lawsuit Andexxa recall lawsuits are being investigated after the FDA linked the drug to an increased risk of thrombotic events, including stroke, heart attack, pulmonary embolism, and fatal blood clots.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Less Than a Third of Pediatric Antibiotic Prescriptions Were Optimal for Choice and Duration: Study Although it is common knowledge that antibiotics do not treat viral infections, doctors often prescribe the drugs to children for that purpose, increasing the risk of antibiotic-resistant superbugs. October 8, 2024 Martha Garcia Add Your Comments Amid continuing efforts to address the medical community’s challenge of antibiotic overuse, which can lead to resistant “superbug” infections, new research shows that only about 30% of antibiotic prescriptions for children are the optimal treatment choice. Superbugs have become an increasing global health threat in recent years, with bacteria and other pathogens developing resistance to existing antibiotics, making them increasingly difficult to treat. To reduce the long-term risk of these antibiotic-resistant infections developing, health experts widely agree that doctors need to make sure antibiotic prescriptions are optimal, especially for children. This includes making sure the drugs are given for the right duration and only for infections that can be treated by the drugs, which should never include viral infections. In a study published in the journal JAMA Network Open on October 3, researchers warn that only 4% of antibiotic prescriptions for children were given for infections that can only be treated by the drugs. Most antibiotics were used in cases where they were not necessarily required, and one-third were rarely required to treat the condition, according to the findings. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In the new study, researchers from Vanderbilt University Medical Center, led by Dr. Brittany J. Lehrer, analyzed 506,000 antibiotic prescriptions from nearly 489,000 pediatric clinical visits in Tennessee in 2022. They used data from IQVIA’s Longitudinal Prescription Claims and Medical Claims databases. The data included clinical visits for patients younger than 20 years old with at least one outpatient oral antibiotic, intramuscular ceftriaxone or penicillin prescription filled in 2022. The study categorized diagnoses into three tiers. Tier 1 diagnoses nearly always required antibiotics to treat the condition, which accounted for about 4% of the prescriptions for children. Tier 2 diagnoses sometimes required antibiotics, accounting for 57% of the prescriptions. However, tier 3 diagnoses included conditions that rarely ever require antibiotics, yet researchers found 39% of prescriptions for children fit into this category. Researchers found that only about 31% of antibiotic prescriptions for children could be considered both appropriate and for the right length of time. About 38% were appropriate, but not for the right duration, and 51% were for the right duration but not appropriate for the condition. For example, ear infections and pharyngitis (severe sore throat) were the most common conditions treated. However, only 67% of ear infection prescriptions and 56% of pharyngitis prescriptions were considered optimal. Lehrer’s team determined prescriptions were often given without considering the most recent evidence to support not needing antibiotics or prescribing for shorter durations. They also said appropriate antibiotic prescribing was more likely in patients who were younger and less socially vulnerable. The study’s authors indicate that additional doctor education is needed to highlight the benefit of shorter antibiotic courses. Additionally, more antibiotic-prescribing interventions are needed to help boost appropriate prescribing. This can also help reduce the creation of antibiotic-resistant superbugs, researchers said. Inappropriate Pediatric Antibiotic Prescriptions According to a report published in September, antibiotic-resistant superbugs could kill nearly 40 million people by 2050 unless drastic measures are taken to reduce the misuse of antibiotics and work is done to create new antibiotic strains. The American Academy of Pediatrics also warns that giving premature infants antibiotics in the first weeks of life increases their risk of suffering serious lung conditions. Antibiotics are often given to preemies as preventive measures instead of to treat a specific infection. In fact, children are often given antibiotics for a number of conditions that antibiotics aren’t effective in treating, including viral conditions. The rise in inappropriate antibiotic prescribing among children has many researchers worried. Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Antibiotic Resistance, Antibiotics, Children, Childrens Drugs, Infection, Medication Error More Lawsuit Stories Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections December 30, 2025 Cartiva Toe Lawsuit Consolidation To Be Considered by JPML in January 2026 December 30, 2025 ByHeart Botulism Cases Taper Off, While Lawsuits and Food Safety Concerns Continue to Build December 30, 2025 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: today) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025) Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (Posted: yesterday) Several major recalls that occurred over the last two years are expected to have a significant impact on medical device and drug litigation throughout 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025) Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 1 week ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITTop Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)
ByHeart Botulism Cases Taper Off, While Lawsuits and Food Safety Concerns Continue to Build December 30, 2025
Lawsuit Alleges Dupixent Caused Cancer Diagnosis After One Year of Injections (Posted: today) A Dupixent lawsuit claims a woman developed T-cell lymphoma after just a year of injections, and must now receive lifelong medical monitoring. MORE ABOUT: DUPIXENT LAWSUITDupixent Cancer Lawsuit Filed Over Cutaneous T-Cell Lymphoma (CTCL) Diagnosis (12/19/2025)Lawyers Propose Dupixent Lawsuit Be Set for Trial After Dec. 6, 2027 (12/11/2025)Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (12/05/2025)
Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (Posted: yesterday) Several major recalls that occurred over the last two years are expected to have a significant impact on medical device and drug litigation throughout 2026. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)
Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (Posted: 1 week ago) A federal judge has scheduled the first Depo-Provera brain tumor pilot trial to begin sometime in December 2026. MORE ABOUT: DEPO-PROVERA LAWSUITTop Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Meningioma Warning Update Approved by FDA, As Lawsuits Move Forward (12/17/2025)Lawsuit Alleges Depo-Provera Neurological Symptoms Were Result of Meningioma (12/12/2025)